Vericel Corporation logo

Vericel Corporation

NASDAQ:VCEL

Overview | Financials
Company Name Vericel Corporation
Symbol VCEL
Currency USD
Price 40.66
Market Cap 2,046,946,380
Dividend Yield 0%
52-week-range 34.87 - 63
Industry Biotechnology
Sector Healthcare
CEO Mr. Dominick C. Colangelo Esq.
Website https://vcel.com

An error occurred while fetching data.

About Vericel Corporation

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single

Related Stocks

Healthcare Services Group, Inc. logo

Healthcare Services Group, Inc.

HCSG

13.38 USD

CareDx, Inc logo

CareDx, Inc

CDNA

12.86 USD

23andMe Holding Co. logo

23andMe Holding Co.

ME

0.606 USD

P3 Health Partners Inc. logo

P3 Health Partners Inc.

PIII

7.3 USD

NextGen Healthcare, Inc. logo

NextGen Healthcare, Inc.

NXGN

23.94 USD

Veracyte, Inc. logo

Veracyte, Inc.

VCYT

23.97 USD

Exscientia plc logo

Exscientia plc

EXAI

4.84 USD

Cytek Biosciences, Inc. logo

Cytek Biosciences, Inc.

CTKB

3.55 USD

Financials

Numbers are in millions USD

Numbers are in millions USD